Principal Investigators (PI’s)
The applicants are established experts in the fields of drug delivery, blood-brain barrier function, receptor-mediated transport, or neurovascular regulation
Department of Neuroscience, University of Copenhagen, Blegdamsvej 3b, 2200 Copenhagen N
Martin Lauritzen is an MD who works with neurological patients and clinical studies of the brain in sepsis and cognitive decline. His translational works concerns brain activity, blood flow and energy use and the blood-brain barrier. Martin is founding member of the steering committee for COSBID, a large multi-center study of patients with acutely injured brain tissue (www.cosbid.org). Martin is currently also one of the team leaders of the Centre for Healthy Aging, and now the Director of RIBBDD.
Thomas Lars Andresen
Deputy Director, Professor
Department of Micro- and Nanotechnology, Produktionstorvet, Building 423, 2800 Kgs. Lyngby
Thomas Andresen is an expert in design and engineering of advanced drug delivery systems for site-specific targeting of therapeutic agents and controlled drug release in normal and diseased tissue Thomas is founder and leader of the DTU Centre of Nanomedicine, which is a research network that currently includes researchers from four DTU departments. At the Department of Micro- and Nanotechnology, DTU, He is furthermore heading strategic research in Biomedical Nanotechnology and Life Sciences.
Morten Schallburg Nielsen
Department of Biomedicine, Aarhus University, Ole Worms Allé, 8000 Aarhus C
Morten Schallburg Nielsen is an expert in molecular and cellbiology studies of cellular transport. Morten is group leader in the MIND centre and in the newly established interdisciplinary centre ‘Membranes’ at University of Aarhus
Laboratory of Neurobiology, Department of Health Science and Technology, Aalborg University, Fredrik Bajers Vej 3, 9220 Aalborg Ø
Torben Moos is an expert in studies of physiological and pathological BBB models in vivo . Torben heads the neurobiology group at Department of Medicine and Health Technology, Aalborg University (AAU) and is the founder and leader of a center for development of targeted therapeutics in treatment of glioblastoma multiforme at AAU.
Faculty of Health Sciences, Department of Pharmacy, Universitetsparken 2, 2100 Copenhagen Ø
PhD Group Leader, Drug Transporters in ADME
PhD defense: Sofie Hørlyck
Dec 11, 2017
Sofie Hørlyck will defend her PhD thesis...
8th RIBBDD biannual meeting
Nov 14, 2017
On October 23-24th 2017, the 8th RIBBDD biannual meeting took place...
Portrait of young scientists
Sep 29, 2017
New series of portraits of our talented young scientists...
Sep 20, 2017
Professor Torben Moos (WP3) has participated in the radio program ”Brinkmann på P1” ...
Sep 01, 2017
New publications from the RIBBDD network...
There are no upcoming events at this time.
All RIBBDD members are highly encourage to actively participate in external events to broader their knowledge